There are 4,072 papers on senescence-associated secretory phenotype (SASP) in aging research: 32 trials and 381 observational studies in people, 1,268 in animals, 846 in cells, 1,463 reviews. The newest story, Nov 16, 2026: “Protein levels alter drug sensitivity in lab-grown human cells”.
SASP induces senescence in human cells, which independent labs reproduce; independent labs also report fisetin reducing SASP in mice. One report instead describes senescence reducing SASP in human cells; SASP is associated with frailty in people with HIV. Some papers declare company ties, and some authors work at companies.
1,406 findings in 1,224 papers from 2008 to 2026, 238 of them since April 2026
Independent labs found the same change in cells, mice and people. 318 independent labs in 41 countries.
“Teeth achieving COM presented significantly lower amounts of SASP factors compared with non-successful teeth.”
Cells, mice and humans: replicated by independent labs. Worms or flies: a single group.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
Includes the processes named after it and trials of drugs aimed at it.
↓downin mice7↓downin human cells4↓downin rats2↓downin cells1+1
15 studies
Dasatinib + quercetin decreases senescence-associated secretory phenotype (SASP) in human fetal lung explants exposed to cannabinoids and nicotine.
“The addition of senolytics, Dasatinib and Quercetin (D + Q), reduced the senescence-associated secretory phenotype (SASP), such as IL-6, IL-8, M-CSF, MCP-3, MIP-1β, TNFα, MIP-3β, and TSLP”
Cellsin human fetal lung explants exposed to cannabinoids and nicotinelung
Dasatinib + quercetin decreases senescence-associated secretory phenotype (SASP) in rats (aged rats with rotator cuff tear repair).
“a significant decrease in the gene expression of senescence markers (p21 and p16) and senescence-associated secretory phenotype factors (IL-6, IL-1β, and MMP-3)”
Animalsaged rats with rotator cuff tear repairsupraspinatus-humerus complex12 weeks after repairn = 24
“Extracellular vesicles (EVs), naturally derived nanoscale membrane vesicles capable of transporting diverse bioactive cargoes across tissues and biological barriers, have emerged as a highly promising platform for regenerative and anti-aging therapeutics.”
“curcumin and resveratrol exhibit the most extensive senotherapeutic activities, followed by ginsenosides, baicalin, myricetin, and other flavonoids, owing to their ability to target multiple senescence-associated signaling pathways and suppress the SASP”
Fisetin decreases senescence-associated secretory phenotype (SASP) in humans (preliminary human studies).
“Preliminary human studies involving FOXO4-axis modulators, such as high-dose fisetin, show a reduction in the senescence-associated secretory phenotype (SASP)”
“Specifically, it suppresses the senescence-associated secretory phenotype (SASP) by inhibiting key inflammatory signaling pathways such as NF-κB and p38-MAPK”
Apigenin prevents senescence-associated secretory phenotype (SASP) in human cells.
“In senescent cells, apigenin blocks the interactions between ATM/p38 and HSPA8, thus preventing transition of the acute stress-associated phenotype (ASAP) towards the SASP.”
↔no changein human cells1↑upin reviews1↑upin rhesus monkeys1
3 studies
Radiation induces senescence-associated secretory phenotype (SASP) in rhesus monkeys (compared with control non-irradiated NHPs).
“In BAL fluid that was collected from WTLI NHP senescence-associated secretory proteins (SASP) were significantly induced, compared to the BAL fluid collected from control non-irradiated NHPs.”
Animalscompared with control non-irradiated NHPswhole-thorax lung irradiationbronchoalveolar lavage
Tazemetostat decreases senescence-associated secretory phenotype (SASP) in humans (ex vivo tendon biopsies).
“Treatment of tendon biopsies with EPZ-6438 reduced secretion of a panel of SASP factors, including interleukin-6 (IL6), IL8, matrix metalloproteinase-3 (MMP3) or GRO1”
“the senescence-associated secretory phenotype (SASP) orchestrates inflammaging and reprograms the CRC microenvironment via pro-inflammatory cytokines, chemokines, and growth factors.”
“the secretion of the senescence-associated secretory phenotype (SASP), rich in proinflammatory cytokines and metalloproteinases, drive inflammaging and oxinflammaging.”
“exhibit a senescence-associated secretory phenotype that can lead to propagation of inflammation, modification of immune-cell function, induce secondary senescence and promote extracellular matrix remodeling”
“These SASP factors not only propagate the senescence phenotype but also disrupt bone homeostasis by impairing the functionality of bone tissue cells, thereby accelerating skeletal aging.”
Senescence-associated secretory phenotype (SASP) mediates extracellular matrix remodeling (via immune cell recruitment, regulation of cell function, and modulation of ECM turnover).
“The SASP, a dynamic cocktail composed of cytokines, chemokines, and proteases, remodels the intrahepatic microenvironment through immune cell recruitment, regulation of cell function, and modulation of ECM turnover.”
Reviewvia immune cell recruitment, regulation of cell function, and modulation of ECM turnoverliver
Senescence-associated secretory phenotype (SASP) impairs extracellular matrix remodeling in humans.
“senescent dermal fibroblasts, keratinocytes and adipocytes secrete a chronic SASP that shifts the Matrix Metalloproteinase (MMP)/Tissue Inhibitor of Metalloproteinase (TIMP) balance toward net proteolysis”
“cellular senescence exacerbates tissue damage through the senescence-associated secretory phenotype (SASP), which promotes inflammation and extracellular matrix degradation.”
Senescence-associated secretory phenotype (SASP) induces extracellular matrix remodeling in humans.
“Aging causes an accumulation of senescent cells that secrete a range of cytokines, growth factors, and enzymes (SASPs), which remodel the ECM, making it stiffer and more degradable”
Senescence-associated secretory phenotype (SASP) mediates immune evasion (much of the evidence derives from preclinical models).
“The senescence-associated secretory phenotype (SASP)-comprising IL-6, IL-8, TGF-β, and matrix metalloproteinases-serves as a central mediator linking cellular senescence to immune evasion and metastatic dissemination”
Reviewmuch of the evidence derives from preclinical models
“SASP, comprising inflammatory cytokines such as IL-6 and IL-8 alongside matrix-remodeling factors, fosters immune evasion, angiogenesis and therapeutic resistance.”
“SASP secretes cytokines, proteases, and growth factors, reshaping the tumor microenvironment (TME) to drive immune evasion, metastasis, and therapy resistance.”
“creates a proinflammatory, profibrotic microenvironment through the senescence-associated secretory phenotype (SASP), thereby promoting tissue damage.”
Reviewchronic accumulation of senescent cellsliver
Senescence-associated secretory phenotype (SASP) activates immune response in vitro.
“the secretion of senescence-associated factors from mesenchymal cells stimulated the activation of T cells and natural killer cells and promoted epithelial cell senescence and cytotoxicity.”
Senescence-associated secretory phenotype (SASP) increases osteoporosis within the inflammaging context.
“the senescence-associated secretory phenotype (SASP) increases IL-6 and TNF-α, which stimulate immunosenescence, osteoporosis, rheumatoid arthritis erosions, and osteosarcopenia.”
“Senescence is characterized by stable cell cycle arrest, metabolic alterations, chromatin remodelling and the secretion of pro-inflammatory and tissue-modifying factors that are collectively termed the senescence-associated secretory phenotype.”
“The Senescence-Associated Secretory Phenotype (SASP) is demonstrated as broadcast from failed recursive return, linking inflammaging, fibrosis, immune exhaustion, tumor permissiveness, immunosenescence, and chronic disease”
Cellular senescence activates senescence-associated secretory phenotype (SASP) in keloid pathology.
“details the spatial heterogeneity of senescent cell accumulation, the activation and pathological effects of senescence-associated secretory phenotype (SASP)”
“damaged mitochondrial DNA leaks into the cytosol to activate the cyclic GMP-AMP synthase-stimulator of interferon genes pathway, amplifying the senescence-associated secretory phenotype”
cGAS–STING signaling increases senescence-associated secretory phenotype (SASP) in aging and neurodegenerative diseases.
“Recent studies have identified an increasing role for activation of the cGAS-STING signaling pathway as a driver of senescence-associated secretory phenotypes (SASPs) in aging and NDDs.”
cGAS–STING signaling mediates senescence-associated secretory phenotype (SASP) in bovine cells (downstream of MSTN in bovine skeletal muscle cells).
“Using cell signaling profiling, MSTN was shown to regulate the SASP, predominantly through the cycle GMP-AMP synthase-stimulator of antiviral genes (cGAS-STING) pathway.”
Cellsdownstream of MSTN in bovine skeletal muscle cells
→mediatesin cells1→is required forin human cells1↑upin human cells1
3 studies
STING1 mediates senescence-associated secretory phenotype (SASP) in cells (downstream of oxidized DNA leakage in cholangiocytes).
“resulting in the production and leakage of oxidized DNA, which facilitates the establishment of senescence-associated secretory phenotype (SASP) by activating STING”
Cellsdownstream of oxidized DNA leakage in cholangiocytescholangiocyte
STING1 is required for senescence-associated secretory phenotype (SASP) in aging, senescent and progeria fibroblasts, shown by cGAS and STING dependence.
“aging/senescent/progeria cells activate inflammatory programs such as the senescence-associated secretory phenotype (SASP) and the interferon (IFN) response, in a cGAS and STING-dependent manner”
Cellsin aging, senescent and progeria fibroblasts, shown by cGAS and STING dependence
↓downin cells1→is required forin human cells1→is required forin reviews1
3 studies
Autophagy is required for senescence-associated secretory phenotype (SASP) (above a critical damage threshold).
“Once this threshold is exceeded, autophagy is functionally reprogrammed to sustain the metabolic and biosynthetic demands of senescent cells, including production of the senescence-associated secretory phenotype (SASP).”
SIRT1 decreases senescence-associated secretory phenotype (SASP) in mouse cells (downstream of 1,25(OH)2D3-enhanced Sirt1 expression).
“which in turn reduced muscle cell senescence and the senescence-associated secretory phenotype (SASP) through decreased levels of acetylated nuclear p53 and p65”
Cellsdownstream of 1,25(OH)2D3-enhanced Sirt1 expressionskeletal muscle
“chronic SASP signaling driven by nuclear factor kB (NF-κB), CCAAT/enhancer-binding protein beta (C/EBPβ), and Signal Transducer and Activator of Transcription 3 (STAT3) fosters epithelial-to-mesenchymal transition (EMT), invasion, and therapy resistance.”
Reviewchronic SASP signaling in tumor microenvironment
DNA damage response induces senescence-associated secretory phenotype (SASP).
“These persistent cell cycle arrests initiated by DDR and other associated stress-induced signals promote a permanent state of cell cycle arrest called senescence-associated secretory phenotype (SASP).”
Senescence-associated secretory phenotype (SASP) raises the risk of cancer (later via sustained SASP in precancer tissue microenvironment).
“later contributing to a pro-tumoral precancer tissue microenvironment (PreTME) via a sustained, paracrine secretome known as senescent-associated secretory phenotype (SASP)”
Reviewlater via sustained SASP in precancer tissue microenvironment
Senescence-associated secretory phenotype (SASP) raises the risk of cancer (through SASP factors influencing the tumor microenvironment).
“Through these SASP factors influencing the tumor microenvironment, senescent cells can be deeply involved in various cancer pathologies such as carcinogenesis and the acquisition of drug resistance.”
Reviewthrough SASP factors influencing the tumor microenvironment
Cellular senescence is associated with senescence-associated secretory phenotype (SASP) in silico.
“Senescent MSCs displayed phenotypic changes, including altered morphology and the emergence of the Senescence-Associated Secretory Phenotype (SASP), which impaired regenerative potential.”
Coffee is associated with senescence-associated secretory phenotype (SASP) in humans (Long-term coffee consumers compared with coffee nondrinking subjects).
“the levels of the senescence-associated secretory phenotype were lower in both long-term coffee consumers and new coffee consumers than in coffee nondrinking subjects”
HumansLong-term coffee consumers compared with coffee nondrinking subjects
KAT5 is associated with senescence-associated secretory phenotype (SASP) in human cells (DNA damage-induced senescence).
“the amplitude of the senescence-associated secretory phenotype (SASP) as measured by transcript and protein levels of secreted factors is dependent on the levels of TIP60.”
CellsDNA damage-induced senescencenormal human fibroblast
CD38 is associated with senescence-associated secretory phenotype (SASP) in donor lungs.
“CD38 expression increased with donor age and ischemic stress, particularly in donation after circulatory death (DCD) allografts, and was associated with senescence-associated secretory phenotype (SASP) signaling.”
Senescence-associated secretory phenotype (SASP) is associated with arterial stiffness in humans.
“proinflammatory secretory phenotype (SASP), which is connected with destabilization of the atherosclerotic plaque, increased arterial stiffness and accelerated atherogenesis.”
Homo sapiens are associated with senescence-associated secretory phenotype (SASP) in IgG4-RD lesions.
“demonstrated positive correlations between age and fibroblast, exhaustion, macrophage/M2, fibrosis-associated macrophage (FAM), inflammaging and senescence-associated secretory phenotype (SASP) signatures”
Independent labs report that SASP induces senescence in rodent cells and that dasatinib plus quercetin reduces SASP in humans. SASP is associated with frailty in people with HIV and induces fibrosis when delivered into mouse lungs; a mouse result instead shows SASP increasing with dasatinib plus quercetin. Two trials ended over a year ago without posted results or linked papers.
Independent labs reproduce SASP-induced senescence in mouse cells and SASP reductions with dasatinib plus quercetin in humans. A human study associates SASP with frailty in people with HIV. Rapamycin inhibits SASP in cells, whereas a human result reports no change.
Summary rewritten as its findings changed.
As it read before
In human cell cultures, vertebrates, and mice, senolytics, lipid nanoparticles, and targeted compounds reduce senescence-associated secretory phenotype (SASP), whereas plastics and CCND2 activate it. Reviews associate SASP with inflammation, extracellular matrix remodeling, and impaired heart function.
Cells still stopped dividing after radiation, but protein levels changed their secreted signals and sensitivity to a drug that kills senescent cells.Cells still stopped dividing after radiation, but protein levels changed their secreted signals and sensitivity to a drug that kills senescent cells.
Stressed human heart-vessel lining cells showed fewer markers of senescence, a state in which cells stop dividing, after 48 hours of particle exposure in laboratory…Stressed human heart-vessel lining cells showed fewer markers of senescence, a state in which cells stop dividing, after 48 hours of particle exposure in laboratory experiments.
Experiments in mice linked smoke exposure to disrupted cell clocks and immune activation, alongside early changes that may leave lungs prone to scarring.Experiments in mice linked smoke exposure to disrupted cell clocks and immune activation, alongside early changes that may leave lungs prone to scarring.